Ginkgo Bioworks’ Datapoints unit launched the Virtual Cell Pharmacology Initiative (VCPI), an open-source project to generate standardized pharmacology datasets and a reference engineered cell line (V-Ref293) for virtual cell model development. Ginkgo plans to test at least 100,000 compounds and produce over 12 billion data points, offering free high-throughput RNA profiling to contributors and sharing master cell bank vials in 2026. John Androsavich framed VCPI as an effort to end reliance on low‑quality training data by providing reproducible, drug-relevant measurements. The initiative aims to unify wet-lab standards and accelerate community validation of AI-driven virtual-cell pharmacology models.